Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP66208.RAafnGXrE5qYXwgHGfJQdYLtIHRu49sLdrWywN0zFU2ZA130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66208.RAafnGXrE5qYXwgHGfJQdYLtIHRu49sLdrWywN0zFU2ZA130_provenance.
• NP59706.RA-65FfEShTC9y3bajyQUV5T0fTOWCWYQQcuYPmZ-uShs130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59706.RA-65FfEShTC9y3bajyQUV5T0fTOWCWYQQcuYPmZ-uShs130_provenance.
• NP61159.RA5G3jqLwCfnyLMH5NCY96p8QLCJG48z9ZhXprBIXGmxI130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61159.RA5G3jqLwCfnyLMH5NCY96p8QLCJG48z9ZhXprBIXGmxI130_provenance.
• NP401188.RAxnJ2LLbLDMj2hQ1ByvLF6ivd8eIsLecnLTslEVfRY18130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401188.RAxnJ2LLbLDMj2hQ1ByvLF6ivd8eIsLecnLTslEVfRY18130_provenance.
• assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP827812.RAYM7l7WycZbHIFxbXMWIq9hxGYyEBj99AiGdNQft2Bkc130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827812.RAYM7l7WycZbHIFxbXMWIq9hxGYyEBj99AiGdNQft2Bkc130_provenance.
• NP827813.RAdu-p757K7MgVi_SfIAm359HAwyEshub5n5yr96zxx0A130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827813.RAdu-p757K7MgVi_SfIAm359HAwyEshub5n5yr96zxx0A130_provenance.
• NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.
• NP66582.RA1-6P1xuYTaDpPX_D-iaP3z0ES2C1m6lOs79U_n0VSrM130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66582.RA1-6P1xuYTaDpPX_D-iaP3z0ES2C1m6lOs79U_n0VSrM130_provenance.
• NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.
• NP182115.RAKpdsYZUac3rC1os6-3a-L-SWtqrXPuPRZowx_4vnYJw130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182115.RAKpdsYZUac3rC1os6-3a-L-SWtqrXPuPRZowx_4vnYJw130_provenance.
• NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.
• NP827811.RA03LLI93jerIEBbyrOm65AfTXTyOBy-remQoHivgXvWU130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827811.RA03LLI93jerIEBbyrOm65AfTXTyOBy-remQoHivgXvWU130_provenance.
• NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.